BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34231107)

  • 1. Biodistribution of
    Hou J; Long T; Yang N; Chen D; Zeng S; Zheng K; Liao G; Hu S
    Mol Imaging Biol; 2021 Dec; 23(6):827-835. PubMed ID: 34231107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of [
    Chen D; Yang S; Chen J; Li T; Liu Y; Zhao X; Zhang T; Xu M; Wang H; Zhao K; Su X
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2420-2431. PubMed ID: 36971805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Application of 18F-AlF-NOTA-Octreotide PET/CT in Combination With 18F-FDG PET/CT for Imaging Neuroendocrine Neoplasms.
    Long T; Yang N; Zhou M; Chen D; Li Y; Li J; Tang Y; Liu Z; Li Z; Hu S
    Clin Nucl Med; 2019 Jun; 44(6):452-458. PubMed ID: 30985413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [
    Pauwels E; Cleeren F; Tshibangu T; Koole M; Serdons K; Dekervel J; Van Cutsem E; Verslype C; Van Laere K; Bormans G; Deroose CM
    Eur J Nucl Med Mol Imaging; 2020 Dec; 47(13):3033-3046. PubMed ID: 32617641
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Pauwels E; Cleeren F; Tshibangu T; Koole M; Serdons K; Boeckxstaens L; Dekervel J; Vandamme T; Lybaert W; den Broeck BV; Laenen A; Clement PM; Geboes K; Cutsem EV; Stroobants S; Verslype C; Bormans G; Deroose CM
    J Nucl Med; 2023 Apr; 64(4):632-638. PubMed ID: 36265911
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis, preclinical evaluation, and a pilot clinical imaging study of [
    Xie Q; Liu T; Ding J; Zhou N; Meng X; Zhu H; Li N; Yu J; Yang Z
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3129-3140. PubMed ID: 33630145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of
    Hou J; Long T; He Z; Zhou M; Yang N; Chen D; Zeng S; Hu S
    EJNMMI Res; 2021 Jun; 11(1):55. PubMed ID: 34106351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Correlation Between [
    Yu J; Li N; Li J; Lu M; Leal JP; Tan H; Su H; Fan Y; Zhang Y; Zhao W; Zhu H; Pomper MG; Zhou Y; Yang Z
    Mol Imaging Biol; 2019 Oct; 21(5):984-990. PubMed ID: 30796708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and Evaluation of [
    Dam JH; Langkjær N; Baun C; Olsen BB; Nielsen AY; Thisgaard H
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological tracer distribution and benign lesion incidental uptake of Al18F-NOTA-FAPI-04 on PET/CT imaging.
    Kou Y; Jiang X; Yao Y; Shen J; Jiang X; Chen S; Lu H; Wang X; Zhao M; Xiao D; Shen T; Zhang W; Cheng Z
    Nucl Med Commun; 2022 Jul; 43(7):847-854. PubMed ID: 35506283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Potential Prognostic Value of Dual-Imaging PET Parameters Based on
    Hou J; Long T; Yang Y; Chen D; Hu S
    Mol Imaging; 2022; 2022():6511179. PubMed ID: 35368455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective Phase II Trial of Prognostication by
    Carlsen EA; Loft M; Loft A; Berthelsen AK; Langer SW; Knigge U; Kjaer A
    J Nucl Med; 2022 Sep; 63(9):1371-1377. PubMed ID: 35058319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Al
    Diao W; Ye Z; Kou Y; Cheng Z
    Hell J Nucl Med; 2024; 27(1):68-70. PubMed ID: 38629821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct comparison of [
    Ahenkorah S; Cawthorne C; Murce E; Deroose CM; Cardinaels T; Seimbille Y; Bormans G; Ooms M; Cleeren F
    Nucl Med Biol; 2023; 118-119():108338. PubMed ID: 37018875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in biodistribution on
    Cherk MH; Kong G; Hicks RJ; Hofman MS
    Cancer Imaging; 2018 Jan; 18(1):3. PubMed ID: 29361984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution and first clinical results of
    Ilhan H; Lindner S; Todica A; Cyran CC; Tiling R; Auernhammer CJ; Spitzweg C; Boeck S; Unterrainer M; Gildehaus FJ; Böning G; Jurkschat K; Wängler C; Wängler B; Schirrmacher R; Bartenstein P
    Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):870-880. PubMed ID: 31492994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of
    Zhang J; Liu Q; Singh A; Schuchardt C; Kulkarni HR; Baum RP
    J Nucl Med; 2020 Nov; 61(11):1560-1569. PubMed ID: 32169914
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Loft M; Carlsen EA; Johnbeck CB; Johannesen HH; Binderup T; Pfeifer A; Mortensen J; Oturai P; Loft A; Berthelsen AK; Langer SW; Knigge U; Kjaer A
    J Nucl Med; 2021 Jan; 62(1):73-80. PubMed ID: 32444370
    [No Abstract]   [Full Text] [Related]  

  • 20. Standardized uptake values and ratios on 68Ga-DOTATATE PET-computed tomography for normal organs and malignant lesions and their correlation with Krenning score in patients with metastatic neuroendocrine tumors.
    Menon BK; Kalshetty A; Bhattacharjee A; Basu S
    Nucl Med Commun; 2020 Oct; 41(10):1095-1099. PubMed ID: 32732598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.